Følg
Shufeng Zhou, MD & PhD
Tittel
Sitert av
Sitert av
År
Guidelines for the use and interpretation of assays for monitoring autophagy
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
Autophagy 17 (1), 1-382, 2021
12950*2021
Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part II
SF Zhou
Clinical Pharmacokinetics 48 (12), 761-804, 2009
11702009
Polymorphism of human cytochrome P450 enzymes and its clinical impact
SF Zhou, JP Liu, B Chowbay
Drug Metabolism Reviews 41 (2), 89-295, 2009
10022009
Herb-drug interactions: a literature review
Z Hu, X Yang, PCL Ho, SY Chan, PWS Heng, E Chan, W Duan, HL Koh, ...
Drugs 65, 1239-1282, 2005
9232005
Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4
SF Zhou
Current Drug Metabolism 9 (4), 310-322, 2008
8252008
Historical perspective of traditional indigenous medical practices: the current renaissance and conservation of herbal resources
SY Pan, G Litscher, SH Gao, SF Zhou, ZL Yu, HQ Chen, SF Zhang, ...
Evidence-Based Complementary and Alternative Medicine 2014 (Volume 2014 …, 2014
7852014
Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition
SF Zhou
Xenobiotica 38 (7-8), 802-832, 2008
7742008
New perspectives on how to discover drugs from herbal medicines: CAM′ S outstanding contribution to modern therapeutics
SY Pan, SF Zhou, SH Gao, ZL Yu, SF Zhang, MK Tang, JN Sun, DL Ma, ...
Evidence‐Based Complementary and Alternative Medicine 2013 (1), 627375, 2013
7382013
Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs
SF Zhou, SY Chan, BC Goh, E Chan, W Duan, M Huang, HL McLeod
Clinical Pharmacokinetics 44 (3), 279-304, 2005
6242005
Herbal modulation of P‐glycoprotein
SF Zhou, LY Lim, B Chowbay
Drug Metabolism Reviews 36 (1), 57-104, 2004
5262004
Interactions of herbs with cytochrome P450
SF Zhou, Y Gao, W Jiang, M Huang, A Xu, JW Paxton
Drug Metabolism Reviews 35 (1), 35-98, 2003
5102003
Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring
SF Zhou, CC Xue, XQ Yu, C Li, G Wang
Therapeutic Drug Monitoring 29 (6), 687-710, 2007
4642007
Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development
SF Zhou, LL Wang, YM Di, CC Xue, W Duan, CG Li, Y Li
Current Medicinal Chemistry 15 (20), 1981-2039, 2008
4442008
Molecular mechanisms for tumor resistance to chemotherapy
ST Pan, ZL Li, ZX He, JX Qiu, SF Zhou
Clinical and Experimental Pharmacology and Physiology 43 (8), 723-737, 2016
4352016
Effects of Ganopoly® (A ganoderma lucidum polysaccharide extract) on the immune functions in advanced‐stage cancer patients
Y Gao, SF Zhou, W Jiang, M Huang, X Dai
Immunological Investigations 32 (3), 201-215, 2003
4202003
Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes
JS Bian, QC Yong, TT Pan, ZN Feng, MY Ali, SF Zhou, PK Moore
Journal of Pharmacology and Experimental Therapeutics 316 (2), 670-678, 2006
4002006
Herbal bioactivation: the good, the bad and the ugly
SF Zhou, HL Koh, Y Gao, Z Gong, EJD Lee
Life Sciences 74 (8), 935-968, 2004
3702004
Pharmacokinetic interactions of drugs with St John’s wort
SF Zhou, E Chan, SQ Pan, M Huang, EJD Lee
Journal of Psychopharmacology 18 (2), 262-276, 2004
3562004
Drug bioactivation covalent binding to target proteins and toxicity relevance
SF Zhou, E Chan, W Duan, M Huang, YZ Chen
Drug Metabolism Reviews 37 (1), 41-213, 2005
3412005
Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2
SF Zhou, B Wang, LP Yang, JP Liu
Drug Metabolism Reviews 42 (2), 268-354, 2010
3142010
Systemet kan ikke utføre handlingen. Prøv på nytt senere.
Artikler 1–20